|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.42 USD | +0.50% |
|
-1.21% | -7.70% |
Business description: HealthEquity, Inc.
Number of employees: 3,113
Sales by Activity: HealthEquity, Inc.
| Fiscal Period: January | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Pharmacy Services | 734M | 757M | 862M | 1B | 1.2B |
Geographical breakdown of sales: HealthEquity, Inc.
| Fiscal Period: January | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States of America | 734M | 757M | 862M | 1B | 1.2B |
Executive Committee: HealthEquity, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Cutler
CEO | Chief Executive Officer | 56 | 2025-01-05 |
James Lucania
DFI | Director of Finance/CFO | 47 | 2023-07-30 |
Elimelech Rosner
CTO | Chief Tech/Sci/R&D Officer | 69 | 2022-02-28 |
Richard E Putnam
IRC | Investor Relations Contact | - | 2016-05-31 |
| Sales & Marketing | - | 2025-09-28 |
Composition of the Board of Directors: HealthEquity, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Neeleman
BRD | Director/Board Member | 58 | 2002-10-31 |
Evelyn Dilsaver
BRD | Director/Board Member | 71 | 2014-07-31 |
Robert Selander
CHM | Chairman | 75 | 2015-09-29 |
Adrian Dillon
BRD | Director/Board Member | 72 | 2016-08-31 |
Gayle Wellborn
BRD | Director/Board Member | 66 | 2017-07-31 |
Debra McCowan
BRD | Director/Board Member | 54 | 2018-03-31 |
Stuart Parker
BRD | Director/Board Member | 64 | 2020-12-03 |
Rajesh Natarajan
BRD | Director/Board Member | 56 | 2022-05-01 |
Scott Cutler
BRD | Director/Board Member | 56 | 2025-01-05 |
Company details: HealthEquity, Inc.
Other Software
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.96% | -0.87% | -18.99% | +49.81% | 7.18B | |
| -0.61% | -1.82% | +5.25% | +85.92% | 3,378B | |
| +0.34% | -5.44% | +130.87% | +2,185.84% | 402B | |
| +0.63% | +2.15% | -2.55% | +47.36% | 97.76B | |
| +1.73% | -0.50% | +0.21% | +69.90% | 83.57B | |
| +0.81% | -3.85% | +118.99% | +2,118.37% | 81.37B | |
| +0.41% | -2.76% | +3.07% | +82.51% | 71.76B | |
| -2.92% | -7.93% | +15.43% | +108.98% | 55.34B | |
| -0.31% | -2.43% | +29.37% | +116.44% | 44.46B | |
| -0.17% | -2.98% | -33.23% | -31.99% | 36.13B | |
| Average | +0.07% | -4.09% | +24.84% | +483.31% | 425.74B | |
| Weighted average by Cap. | -0.44% | -3.76% | +18.98% | +321.19% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HQY Stock
- Company HealthEquity, Inc.
Select your edition
All financial news and data tailored to specific country editions
